Assessment of safety and efficacy of ferric carboxymaltose (Ferinject ®) in the management of iron deficiency with anaemia (IDA) or without anaemia in children and adolescents with inflammatory bowel disease (IBD)

被引：0
|
作者：
Hachemi, S. [1 ]
Mutalib, M. [1 ]
Chadokufa, S. [1 ]
Huggett, B. [1 ]
Sider, S. [1 ]
Shah, N. [1 ]
Whitley, L. [2 ]
McCartney, S. [2 ]
Kiparissi, F. [1 ,2 ]
机构：
[1] Great Ormond St Hosp Sick Children, Paediat Gastroenterol, London WC1N 3JH, England
[2] Univ Coll London Hosp NHS Fdn Trust, Dept Gastroenterol, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P377
引用
收藏
页码：S267 / S267
页数：1
相关论文
共 50 条
  • [21] Safety and Efficacy of Ferric Carboxymaltose in Pediatric Inflammatory Bowel Disease
    Favreau, Alexander
    Langseder, Annette
    Neier, Michele
    Rosh, Joel
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S66 - S66
  • [22] Anaemia and iron deficiency in pediatric inflammatory bowel disease
    Martin de Carpi, J.
    Pina Jover, M.
    Pujol Muncunill, G.
    Varea Calderon, V.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S184 - S184
  • [23] Effects of ferric derisomaltose and ferric carboxymaltose on hypophosphatemia in iron-deficiency anaemia due to Inflammatory Bowel Disease: A Phase IV randomised clinical trial
    Zoller, H.
    Wolf, M.
    Blumenstein, I.
    Primas, C.
    Lindgren, S.
    Thomsen, L. L.
    Reinisch, W.
    Iqbal, I.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S121 - S121
  • [24] Intravenous (IV) ferumoxytol (FER) for the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease (IBD): Efficacy, safety and health-related quality of life (HRQOL)
    Hetzel, D.
    Ford, D.
    Dahl, N.
    Strauss, W.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S248 - S249
  • [25] Ferric carboxymaltose in the treatment of iron deficiency in pediatric inflammatory bowel disease
    Carman, Nicholas
    Muir, Richard
    Lewindon, Peter
    TRANSLATIONAL PEDIATRICS, 2019, 8 (01) : 28 - 34
  • [26] Management of Iron Deficiency Anaemia in Inflammatory Bowel Disease with Special Emphasis on Intravenous Iron
    Dignass, Axel U.
    Stein, Juergen
    PRACTICAL GASTROENTEROLOGY, 2011, 35 (10) : 17 - 30
  • [27] Ferric maltol in iron deficiency anaemia in patients with inflammatory bowel disease: a guide to its use
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2016, 32 (6) : 226 - 231
  • [28] Efficacy and Safety of Intravenous Ferric Carboxymaltose Treatment of Iron Deficiency Anaemia in Patients with Corpus Atrophic Gastritis: A Retrospective Study
    Dottori, Ludovica
    Tsar'kov, Daniil Corleone
    Dilaghi, Emanuele
    Pivetta, Giulia
    Scalamonti, Silvia
    Ligato, Irene
    Esposito, Gianluca
    Annibale, Bruno
    Lahner, Edith
    NUTRIENTS, 2023, 15 (19)
  • [29] Iron Status and Analysis of Efficacy and Safety of Ferric Carboxymaltose Treatment in Patients with Inflammatory Bowel Disease
    Beigel, Florian
    Loehr, Beate
    Laubender, Ruediger P.
    Tillack, Cornelia
    Schnitzler, Fabian
    Breiteneicher, Simone
    Weidinger, Maria
    Goeke, Burkhard
    Seiderer, Julia
    Ochsenkuehn, Thomas
    Brand, Stephan
    DIGESTION, 2012, 85 (01) : 47 - 54
  • [30] Interventions for treating iron deficiency anaemia in inflammatory bowel disease
    Gordon, Morris
    Sinopoulou, Vassiliki
    Iheozor-Ejiofor, Zipporah
    Iqbal, Tariq
    Allen, Patrick
    Hoque, Sami
    Engineer, Jaina
    Akobeng, Anthony K.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (01):
12345